Drug Research
EC approves Regeneron-Sanofi’s Dupixent for eosinophilic esophagitis
The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE).
Dupixent’s expanded authorisation in the European...
Drug Research
Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston
Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. that serves as one of the company’s global...
Drug Research
Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
Eli Lilly and Company announced plans to invest an additional $450 million and create at least 100 new jobs to expand its manufacturing capacity at...
Drug Research
SK bioscience introduces new partnership model to establish regional vaccine hubs
SK bioscience, a global innovative vaccine and biotech company, introduced a new global partnership model under the title of ‘Preparing for Next Pandemic through Global...
Drug Research
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, announced the opening of a new commercial-scale plasmid DNA (pDNA)...
Drug Research
Zennova Pharmaceuticals Opens Manufacturing and R&D Center in China
Zennova Pharmaceuticals, a Princeton, NJ-based development stage pharmaceutical company focused on complex ophthalmic suspensions and emulsions, hosted a dedication for its manufacturing plant and R&D...
Drug Research
PIK-75 May End Up Being A Saviour Drug For Acute Leukaemia
National University of Singapore researchers have gone ahead and revisited a drug which they believe can be a problem solver when it comes to acute...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.